Protein Metrics develops vendor-neutral software for analysing mass spectrometry data, a critical tool in protein characterisation, quantification, and proteomics research. Its platform is designed to support biotherapeutic analytical studies from early-stage research through to industrial production, using proprietary algorithms to help scientists identify proteins and derive more accurate results from complex datasets.
The company's technology spans liquid chromatography, capillary electrophoresis, and multiple mass spectrometry platforms. It operates in sectors including biomarker and biologic drug discovery, vaccines, and biologics development. Protein Metrics holds 30 patents and is part of the broader Dotmatics organisation.
The firm maintains a collaborative working culture and emphasises keeping its software aligned with advances in analytical instrumentation, leveraging best-in-class approaches across a range of scientific techniques.
